Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms
In vitro dissolution testing is widely used to mimic and predict in vivo performance of oral drug products in the gastrointestinal (GI) tract. This literature review assesses the current in vitro dissolution methodologies being employed to simulate and predict in vivo drug dissolution under fasted a...
Gespeichert in:
Veröffentlicht in: | The AAPS journal 2022-03, Vol.24 (2), p.40-40, Article 40 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In vitro
dissolution testing is widely used to mimic and predict
in vivo
performance of oral drug products in the gastrointestinal (GI) tract. This literature review assesses the current
in vitro
dissolution methodologies being employed to simulate and predict
in vivo
drug dissolution under fasted and fed conditions, with emphasis on immediate release (IR) solid oral dosage forms. Notable human GI physiological conditions under fasted and fed states have been reviewed and summarized. Literature results showed that dissolution media, mechanical forces, and transit times are key dissolution test parameters for simulating specific postprandial conditions. A number of biorelevant systems, including the fed stomach model (FSM), GastroDuo device, dynamic gastric model (DGM), simulated gastrointestinal tract models (TIM), and the human gastric simulator (HGS), have been developed to mimic the postprandial state of the stomach. While these models have assisted in expanding physiological relevance of
in vitro
dissolution tests, in general, these models lack the ability to fully replicate physiological conditions/processes. Furthermore, the translatability of
in vitro
data to an
in vivo
system remains challenging. Additionally, physiologically based pharmacokinetic (PBPK) modeling has been employed to evaluate the effect of food on drug bioavailability and bioequivalence. Here, we assess the current status of
in vitro
dissolution methodologies and absorption PBPK modeling approaches to identify knowledge gaps and facilitate further development of
in vitro
dissolution methods that factor in fasted and fed states. Prediction of
in vivo
drug performance under fasted and fed conditions
via in vitro
dissolution testing and modeling may potentially help efforts in harmonizing global regulatory recommendations regarding
in vivo
fasted and fed bioequivalence studies for solid oral IR products.
Graphical abstract |
---|---|
ISSN: | 1550-7416 1550-7416 |
DOI: | 10.1208/s12248-022-00690-5 |